The automated analyzers market provides various advantages like accurate and quick testing capabilities, high productivity and reduced operational costs. With the increased cases of chronic and infectious diseases, there is growing need for clinical diagnostics. Automated analyzers help process large number of samples within short duration and eliminate manual errors.
The Global automated analyzers Market is estimated to be valued at US$ 5.56 Bn in 2024 and is expected to exhibit a CAGR of 9.9% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the automated analyzers are Abbott, Danaher, Thermo Fisher Scientific, Inc., Becton Dickinson, Agilent Technologies, Inc., Zimed Healthcare Inc., Biobase Biodusty(Shandong), Co., Ltd., Chongqing Drawell Instrument CO,.Ltd, Transasia Bio-Medicals, Awareness Technology, Inc., Trivitron Healthcare, Getein Biotech, Inc., Eppendorf AG, Honeywell International, Inc., Aurora Biomed, HORIBA, Ltd., Beckman Coulter, Inc.
The increasing prevalence of chronic and infectious diseases has boosted the demand for Automated Analyzers Market Growth. Various technological advancements like artificial intelligence integrated systems, robotic analyzers, server based architecture and enhanced analytical capabilities are expanding the scope of automated analyzers market.
Market Trends
Growing adoption of fully automated analyzers – Fully automated analyzers with integrated robotics for sample handling, analysis and automated diagnosis are gaining popularity. They offer high throughput of 500-1000 tests/hour.
Integration of AI and IoT – Major players are focusing on integrating automated analyzers with AI, IoT and cloud based technologies. This is improving efficiency, reducing errors and enabling remote monitoring.
Market Opportunities
Emerging markets in Asia Pacific and Latin America – Growing healthcare infrastructure and increasing healthcare expenditure in developing nations will boost the demand in these regions.
Point of care testing – Miniaturized portable automated analyzers for point of care near patient setting diagnoses are opening new application areas. This improves access and turnaround time for patients.
Impact of COVID-19 on Automated Analyzers Market
The COVID-19 pandemic has significantly impacted the growth of the automated analyzers market. During the initial outbreak, there was an unprecedented demand for diagnostic testing which led to shortages in automated analyzers and related consumables. Manufacturers struggled to meet this sudden surge in demand. Governments and healthcare systems prioritized COVID-19 testing which diverted resources away from routine healthcare. This negatively impacted the procurement and installation of new automated analyzers in hospitals and laboratories. However, as the pandemic progressed, manufacturers ramped up production capacities and supply chains stabilized. The pandemic also highlighted the importance of rapid and automated laboratory testing in disease management and control. This is expected to drive increased adoption of automated analyzers going forward for relief in workloads and quicker turnaround times. The market is projected to grow at a higher rate during the forecast period as healthcare systems strengthen laboratory infrastructure and focus on automating more testing procedures.
North America currently holds the largest share of the automated analyzers market in terms of value owing to rapid adoption of advanced technologies, large healthcare expenditures, and presence of major manufacturers. The region is expected to continue dominating the market during the forecast period driven by rising incidence of chronic and infectious diseases, aging population, and growing automation in clinical laboratories. Asia Pacific is poised to be the fastest growing regional market due to improving accessibility to healthcare services, rising healthcare spending, increasing collaborations between global players and regional diagnostic companies, and growing public awareness about the benefits of laboratory automation. China, India, and South Korea will drive high market growth rates in Asia Pacific. Japan also represents an important automated analyzers market supported by advanced clinical research infrastructure and healthcare facilities.
Europe currently accounts for the second largest share of the global automated analyzers market. This can be attributed to well-established healthcare systems, rising demand for early disease diagnosis, presence of leading market players, and government support for adoption of advanced medical technologies. However, market growth in Europe may be hampered by budget constraints and fiscal difficulties faced by several countries. Overall, the automated analyzers market is anticipated to show healthy gains across all major geographic regions over the forecast period backed by growing need for efficient laboratory automation.
Get more insights on Automated Analyzers Market